Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Jasper Therapeutics, Inc. (JSPR) had Current Assets of $34.65M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.10M |
|
-- |
|
-- |
|
$15.84M |
|
$-15.84M |
|
$6.74M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-9.10M |
|
$-15.84M |
|
$-15.55M |
|
19.17M |
|
19.17M |
|
$0.33 |
|
$0.33 |
|
| Balance Sheet Financials | |
|
Current Assets |
$34.65M |
$0.10M |
|
$1.13M |
|
$35.78M |
|
$13.20M |
|
-- |
|
$18.43M |
|
$31.63M |
|
$4.15M |
|
$4.15M |
|
$4.15M |
|
28.00M |
|
| Cash Flow Statement Financials | |
$-77.16M |
|
$0.01M |
|
$34.21M |
|
$72.05M |
|
$29.11M |
|
$-42.95M |
|
$6.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-77.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-219.25% |
|
-219.25% |
|
-25.44% |
|
-219.25% |
|
$0.15 |
|
$-4.03 |
|
$-4.03 |
|